Avista Healthcare Public Acquisiton Corp (NASDAQ:AHPA): Andrew Feldstein And Stephen Siderow’s Blue Mountain Capital filed an amended 13D.
You can check out Blue Mountain Capital’s latest holdings and filings here.
Please follow Blue Mountain Capital (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Blue Mountain Capital or update its stock holdings.
Follow Andrew Feldstein And Stephen Siderow's Blue Mountain Capital
You can access the original SEC filing by clicking here.
Ownership Summary Table
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
BlueMountain Capital Management | 0 | 2,040,718 | 0 | 2,040,718 | 2,040,718 | 6.6% |
Blue Mountain Credit Alternatives Master Fund | 0 | 0 | 0 | 0 | 0 | 0.0% |
Follow Andrew Feldstein And Stephen Siderow's Blue Mountain Capital
Page 1 of 6 – SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
AVISTA
HEALTHCARE PUBLIC ACQUISITION CORP.
(Name of Issuer)
Class A Ordinary Share, par value $0.0001 per share
(Title of Class of Securities)
G0726L109
(CUSIP Number)
November 28, 2017
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to
designate the rule pursuant to which this Schedule is filed:
☐ | Rule 13d-1(b) |
☒ | Rule 13d-1(c) |
☐ | Rule 13d-1(d) |
* | The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. |
The information required on the remainder of this cover page shall not be
deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the
Act (however, see the Notes).
Follow Organogenesis Holdings Inc. (NASDAQ:ORGO)
Follow Organogenesis Holdings Inc. (NASDAQ:ORGO)
Page 2 of 6 – SEC Filing
CUSIP No. G0726L109 | 13G | Page 2 of 6 Pages |
1. | NAMES OF BlueMountain Capital | |||||
2. | CHECK THE APPROPRIATE BOX IF A MEMBER (a) ☐ (b) ☒ | |||||
3. | SEC USE ONLY | |||||
4. | CITIZENSHIP OR PLACE OF Delaware, United States of America | |||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER 0 | ||||
6. | SHARED VOTING POWER 2,040,718 | |||||
7. | SOLE DISPOSITIVE POWER 0 | |||||
8. | SHARED DISPOSITIVE POWER 2,040,718 | |||||
9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,040,718 | |||||
10. | CHECK IF THE AGGREGATE AMOUNT IN ROW ☐ | |||||
11. | PERCENT OF CLASS REPRESENTED BY AMOUNT 6.6% (1) | |||||
12. | TYPE OF REPORTING PERSON (see IA |
(1) | The percentage set forth in Row 11 of this Cover Page is based on the 31,000,000 shares of Ordinary Shares (as defined herein) of the Issuer (as defined herein) outstanding as of November 14, 2017, as reported on the Issuers Form 10-Q filed with the Securities and Exchange Commission on November 14, 2017 (Form 10-Q). |
Follow Organogenesis Holdings Inc. (NASDAQ:ORGO)
Follow Organogenesis Holdings Inc. (NASDAQ:ORGO)
Page 3 of 6 – SEC Filing
CUSIP No. G0726L109 | 13G | Page 3 of 6 Pages |
1. | NAMES OF Blue Mountain Credit | |||||
2. | CHECK THE APPROPRIATE BOX IF A MEMBER (a) ☐ (b) ☒ | |||||
3. | SEC USE ONLY | |||||
4. | CITIZENSHIP OR PLACE OF Cayman Islands | |||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER 0 | ||||
6. | SHARED VOTING POWER 0 | |||||
7. | SOLE DISPOSITIVE POWER 0 | |||||
8. | SHARED DISPOSITIVE POWER 0 | |||||
9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 | |||||
10. | CHECK IF THE AGGREGATE AMOUNT IN ROW ☐ | |||||
11. | PERCENT OF CLASS REPRESENTED BY AMOUNT 0.0% (1) | |||||
12. | TYPE OF REPORTING PERSON (see PN |
(1) | The percentage set forth in Row 11 of this Cover Page is based on the 31,000,000 shares of Ordinary Shares of the Issuer outstanding as of November 14, 2017, as reported on Form 10-Q. |
Follow Organogenesis Holdings Inc. (NASDAQ:ORGO)
Follow Organogenesis Holdings Inc. (NASDAQ:ORGO)
Page 4 of 6 – SEC Filing
CUSIP No. G0726L109 | 13G | Page 4 of 6 Pages |
Item 1.
(a) | Name of Issuer |
Avista Healthcare Public Acquisition Corp.
(b) | Address of Issuers principal executive offices |
65 East 55th Street, 18th Floor,
New York, New York 10022
Item 2.
(a) | Name of person filing |
This Amendment No. 1 (this Amendment) to
the Schedule 13G filed on October 19, 2016 is being filed on behalf of BlueMountain Capital Management, LLC (BMCM) and Blue Mountain Credit Alternatives Master Fund L.P. (BMCA) with respect to the shares of
Class A Ordinary Shares, $0.0001 par value per share (the Ordinary Shares), of Avista Healthcare Public Acquisition Corp., a Cayman Islands exempted company (the Issuer).
BMCM, which is the beneficial owner of 1,623,446 shares of Ordinary Shares, acts as investment manager to, and exercises investment discretion
with respect to the following beneficial owners of Ordinary Shares (each, a BlueMountain Fund):
(i) | BlueMountain Foinaven Master Fund L.P., a Cayman Islands exempted limited partnership, with respect to the 86,800 shares of Ordinary Shares directly owned by it; |
(ii) | BlueMountain Montenvers Master Fund SCA SICAV-SIF, an investment company with variable capital organized as a specialized investment fund in the form of a corporate partnership limited by shares under the laws of Luxembourg, with respect to the 187,509 shares of Ordinary Shares directly owned by it; |
(iii) | BlueMountain Guadalupe Peak Fund L.P., a Delaware limited partnership, with respect to the 61,600 shares of Ordinary Shares directly owned by it; and |
(iv) | BlueMountain Kicking Horse Fund L.P., a Cayman Islands exempted limited partnership, with respect to the 81,363 shares of Ordinary Shares directly owned by it. |
The filing of this statement should not be construed as an admission that BMCM is, for the purpose of Section 13 of the Act, the
beneficial owner of the Ordinary Shares owned by the BlueMountain Funds.
(b) | Address or principal business office or, if none, residence |
280 Park Avenue, 12th
Floor, New York, New York 10017
(c) | Citizenship |
See Row 4 of each Cover Page.
(d) | Title of class of securities |
Class A Ordinary Shares, par value $0.0001 per share
(e) | CUSIP No. |
G0726L109
Item 3. If this statement is filed pursuant to §§240.13d-1(b) or
240.13d-2(b) or (c), check whether the person filing is a:
(a) | ☐ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). |
(b) | ☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). |
(c) | ☐ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). |
Follow Organogenesis Holdings Inc. (NASDAQ:ORGO)
Follow Organogenesis Holdings Inc. (NASDAQ:ORGO)
Page 5 of 6 – SEC Filing
CUSIP No. G0726L109 | 13G | Page 5 of 6 Pages |
(d) | ☐ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). |
(e) | ☐ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); |
(f) | ☐ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); |
(g) | ☐ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); |
(h) | ☐ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
(i) | ☐ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); |
(j) | ☐ Group, in accordance with §240.13d-1(b)(1)(ii)(K). |
Item 4. Ownership.
The information required by
Items 4(a)-(c) is set forth in Rows 5-11 of each Cover Page and is incorporated herein by reference.
BMCM
expressly declares that this filing shall not be construed as an admission that it is, for the purposes of Sections 13(d) or 13(g) of the Act, the beneficial owner of the securities owned by the BlueMountain Funds.
Item 5. Ownership of 5 Percent or Less of a Class.
This Amendment constitutes an exit filing for BMCA.
If this
statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐.
Item 6. Ownership of More than 5 Percent on Behalf of Another Person.
Not applicable.
Item 7. Identification and
Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of
Group.
Not applicable.
Item 10. Certification.
By signing below I
certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not
acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
Follow Organogenesis Holdings Inc. (NASDAQ:ORGO)
Follow Organogenesis Holdings Inc. (NASDAQ:ORGO)
Page 6 of 6 – SEC Filing
CUSIP No. G0726L109 | 13G | Page 6 of 6 Pages |
SIGNATURES
After reasonable inquiry and to the best of each of the undersigneds knowledge and belief, each of the undersigned certifies that the information set
forth in this statement is true, complete and correct.
DATED: December 8, 2017
BLUEMOUNTAIN CAPITAL MANAGEMENT, LLC
By: | /s/ Eric M. Albert | |
Eric M. Albert, Chief Compliance Officer |
BLUE MOUNTAIN CREDIT ALTERNATIVES MASTER FUND L.P.
By: Blue Mountain CA Master Fund GP, Ltd.
By: | /s/ Andrew Feldstein | |
Andrew Feldstein, Director |